NPPB and heart failure: BNP and NT‐proBNP have proven to be sufficient biomarkers for ruling in and ruling out heart failure in patients already presenting with dyspnea; however, there is a clear need for biomarkers that predict heart failure earlier in disease progression to allow for intervention before remodeling becomes irreversible.